高危新生儿早期肠外营养“再喂养综合征”临床防治进展

doi:10.12372/jcp.2025.24e0103

Abstract

Abstract:

Refeeding syndrome is a metabolic disorder characterized by electrolyte disorder, mainly low phosphorus, low potassium and low magnesium, and its clinical manifestations are non-specific and diverse. It is common in malnourished and severe adult patients and is also found in high-risk newborns who receive early parenteral nutrition treatment. This article reviews the physiological mechanism, risk factors, clinical characteristics, prevention and treatment of parenteral nutrition-related neonatal refeeding syndrome.

Key words: refeeding syndrome, parenteral nutrition, newborn

DING Wenwen, ZHU Feng, LUO Yujia, WEI Li. Clinical progress in prevention and treatment of early parenteral nutrition-related "refeeding syndrome" in high-risk newborns[J].Journal of Clinical Pediatrics, 2025, 43(1): 56-60.

References 26

[1]	da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome[J]. Nutr Clin Pract, 2020, 35(2): 178-195. doi: 10.1002/ncp.10474 pmid: 32115791
[2]	Cormack BE, Jiang Y, Harding JE, et al. Neonatal refeeding syndrome and clinical outcome in extremely low-birth-weight babies: Secondary cohort analysis from the ProVIDe trial[J]. JPEN J Parenter Enteral Nutr, 2021, 45(1): 65-78.
[3]	Parramón-Teixidó CJ, Gómez-Ganda L, Garcia-Palop B, et al. The influence of parenteral protein intake on electrolyte disturbances in premature infants[J]. An Pediatr (Engl Ed), 2021, 95(3): 139-146.
[4]	Robinson DT, Taylor SN, Moya F. Preterm infant nutrition: considerations for infants at risk of refeeding syndrome[J]. J Perinatol, 2023, 43(1): 120-123.
[5]	Bradford CV, Cober MP, Miller JL. Refeeding syndrome in the neonatal intensive care unit[J]. J Pediatr Pharmacol Ther, 2021, 26(8): 771-782. doi: 10.5863/1551-6776-26.8.771 pmid: 34790066
[6]	Huang X, Anderle P, Hostettler L, et al. Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia[J]. BMC Genomics, 2018, 19(1): 173. doi: 10.1186/s12864-018-4518-z pmid: 29499643
[7]	Ross JR, Finch C, Ebeling M, et al. Refeeding syndrome in very-low-birth-weight intrauterine growth-restricted neonates[J]. J Perinatol, 2013, 33(9): 717-720. doi: 10.1038/jp.2013.28 pmid: 23538644
[8]	邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 第5版. 北京: 人民卫生出版社, 2019.
	Shao XM, Ye HM, Qiu XS. Practical neonatology[M]. 5^th ed. Beijing: People's Medical Publishing House, 2019.
[9]	Koekkoek W, Van Zanten A. Is refeeding syndrome relevant for critically ill patients?[J]. Curr Opin Clin Nutr Metab Care, 2018, 21(2): 130-137.
[10]	Senterre T, Abu Zahirah I, Pieltain C, et al. Electrolyte and mineral homeostasis after optimizing early macronutrient intakes in VLBW infants on parenteral nutrition[J]. J Pediatr Gastroenterol Nutr, 2015, 61(4): 491-498.
[11]	Dreyfus L, Fischer Fumeaux CJ, Remontet L, et al. Low phosphatemia in extremely low birth weight neonates: a risk factor for hyperglycemia?[J] Clin Nutr, 2016, 35(5): 1059-1065. doi: 10.1016/j.clnu.2015.07.019 pmid: 26302852
[12]	Pająk A, Królak-Olejnik B, Szafrańska A. Early hypophosphatemia in very low birth weight preterm infants[J]. Adv Clin Exp Med, 2018, 27(6): 841-847. doi: 10.17219/acem/70081 pmid: 29790700
[13]	Igarashi A, Okuno T, Ohta G, et al. Risk factors for the development of refeeding syndrome-like hypophosphatemia in very low birth weight infants[J]. Dis Markers, 2017, 2017: 9748031.
[14]	Bustos Lozano G, Soriano-Ramos M, Pinilla Martín MT, et al. Early hypophosphatemia in high-risk preterm infants: efficacy and safety of sodium glycerophosphate from first day on parenteral nutrition[J]. JPEN J Parenter Enteral Nutr, 2019, 43(3): 419-425. doi: 10.1002/jpen.1426 pmid: 30070716
[15]	Boullata JI, Mirtallo JM, Sacks GS, et al. Parenteral nutrition compatibility and stability: a comprehensive review[J]. JPEN J Parenter Enteral Nutr, 2022, 46(2): 273-299.
[16]	Mihatsch WA, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition[J]. Clin Nutr, 2018, 37(6 Pt B): 2303-2305. doi: S0261-5614(18)30215-2 pmid: 30471662
[17]	Manzetti S, Zhang J, van der Spoel D. Thiamin function, metabolism, uptake, and transport[J]. Biochemistry, 2014, 53(5): 821-835. doi: 10.1021/bi401618y pmid: 24460461
[18]	Hiffler L, Rakotoambinina B, Lafferty N, et al. Thiamine deficiency in tropical pediatrics: new insights into a neglected but vital metabolic challenge[J]. Front Nutr, 2016, 3: 16. doi: 10.3389/fnut.2016.00016 pmid: 27379239
[19]	Bradley C, Hansen A, Levy P, et al. Recognizing neonatal refeeding syndrome and thiamin supplementation: a case report[J]. JPEN J Parenter Enteral Nutr, 2023, 47(3): 437-441.
[20]	中华医学会肠外肠内营养学分会儿科学组, 中华医学会儿科学分会新生儿学组, 中华医学会小儿外科学分会新生儿外科学组, 等. 中国新生儿营养支持临床应用指南[J]. 中华小儿外科杂志, 2013, 34(10): 782-787.
	Group of Pediatrics, Parenteral and Enteral Nutrition Society, Chinese Medical Association; Group of Neonatology, Pediatric Society, Chinese Medical Association; Group of Neonatology, Pediatric Surgical Society, Chinese Medical Association. Chinese guideline for newborn nutrition support in neonates[J]. Zhonghua Xiaoer Waike Zazhi, 2013, 34(10): 782-787.
[21]	Embleton ND, Jennifer MS, Lapillonne A, et al. Enteral nutrition in preterm infants (2022): a position paper from the ESPGHAN committee on nutrition and invited experts[J]. J Pediatr Gastroenterol Nutr, 2023, 76(2): 248-268.
[22]	Thoene M, Anderson-Berry A. Early enteral feeding in preterm infants: a narrative review of the nutritional, metabolic, and developmental benefits[J]. Nutrients, 2021, 13(7): 2289.
[23]	Dorling J, Abbott J, Berrington J, et al. Controlled trial of two incremental milk-feeding rates in preterm infants[J]. N Engl J Med, 2019, 381(15): 1434-1443.
[24]	Young L, Oddie SJ, McGuire W. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants[J]. Cochrane Database Syst Rev, 2022, 1(1): CD001970.
[25]	Yakubovich D, Strauss T, Ohana D, et al. Factors associated with early phosphate levels in preterm infants[J]. Eur J Pediatr, 2020, 179(10): 1529-1536. doi: 10.1007/s00431-020-03622-7 pmid: 32248319
[26]	2020 NICE Guideline. Neonatal parenteral nutrition[EB/OL]. [2024-02-06]. www.nice.org.uk/guidance/ng154.

Clinical progress in prevention and treatment of early parenteral nutrition-related "refeeding syndrome" in high-risk newborns

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 15

Metrics

Comments

Recommended 0

[1]	GAO Xiaolan, LIANG Huan, CHEN Guoqing, ZHANG Huiwen, HAN Lianshu, QIU Wenjuan, GU Xuefan. Exploring the feasibility of enzyme activity assay of dried blood spots for newborn screening of mucopolysaccharidosis type Ⅱ [J]. Journal of Clinical Pediatrics, 2025, 43(3): 191-198.
[2]	LIU Qingyu, WANG Liwei, LIN Yilin, XIAO Rui, ZHOU Hui, ZHANG Xiaoqian, FU Mengran, MI Hongying. Genetic variation analysis of neonatal hyperbilirubinemia: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 782-786.
[3]	ZHU Yan, SUN Yuguang, XIA Song, XIN Jianfeng, SHEN Wenbin. Clinical analysis of 4 cases with primary intestinal lymphangiectasia in infants [J]. Journal of Clinical Pediatrics, 2024, 42(8): 709-713.
[4]	LI Qiang, CHEN Chi, ZHOU Ying, MAO Huaqing, XU Yihong, XU Yanhua. Analysis of the effect of optimized quality control system and evaluation indicators on the screening efficiency of neonatal genetic metabolic diseases [J]. Journal of Clinical Pediatrics, 2024, 42(6): 515-519.
[5]	ZHOU Meijuan, LI Hong, WANG Qing. Clinical analysis of neonatal lupus erythematosus [J]. Journal of Clinical Pediatrics, 2024, 42(6): 543-546.
[6]	SUN Yuning, LIANG Lili, DING Si, LIU Yuchao, CHEN Ting, GONG Zhuwen, QIU Wenjuan, ZHANG Huiwen, GU Xuefan, HAN Lianshu. Clinical characteristics, genotypes and follow-up analysis of children with isovaleric academia [J]. Journal of Clinical Pediatrics, 2024, 42(3): 224-229.
[7]	HUANG Cidan, XU Haizhu, WEN Yingmei, LIU Xiulian. Analysis of the results of newborn screening for fatty acid oxidative metabolic diseases in ethnic minority areas of Hainan Province [J]. Journal of Clinical Pediatrics, 2024, 42(2): 133-138.
[8]	ZHAO Zhengyan. The forty-three year development of newborn screening in china: starting with Chen Ruiguan [J]. Journal of Clinical Pediatrics, 2024, 42(2): 89-92.
[9]	CHEN Wenwen, DAI Shuzhen, XU Liping. Clinical features, treatments, and outcomes of neonatal arrhythmia [J]. Journal of Clinical Pediatrics, 2023, 41(7): 507-513.
[10]	HUANG Lilian, CHEN Jielin, LI Yingqiao, PANG Xialing, TAN Jie, HUANG Huiping, FENG Yanhua, Qin Min, LUO Jingsi. Clinical and genetic analysis of neonatal onset chronic granulomatous disease [J]. Journal of Clinical Pediatrics, 2023, 41(6): 464-469.
[11]	CHEN Yan, WANG Lin. Attention should be paid to neonatal hyperammonemia [J]. Journal of Clinical Pediatrics, 2023, 41(4): 247-251.
[12]	LIANG Lili. Genetic classification, diagnosis, and treatment of hyperphenylalaninemia [J]. Journal of Clinical Pediatrics, 2023, 41(2): 92-97.
[13]	MA Cuixia, Feng Lulu, Ma Qianqian, Li Yang, Feng Jizhen. Screening of newborns with hyperphenylalaninemia and analysis of PAH gene mutation and deletion [J]. Journal of Clinical Pediatrics, 2023, 41(2): 98-102.
[14]	WANG Yingyuan, FANG Panpan, CHEN Mengmeng, GUO Jing, LIU Dapeng, KANG Wenqing. Analysis of clinical features and gene mutations in five neonates with CHARGE syndrome [J]. Journal of Clinical Pediatrics, 2023, 41(11): 846-851.
[15]	LU Xiaoyan, CHEN Shaohong, CHEN Yingying, ZHOU Wenjun, ZHOU Chan, SONG Yan, LI Luquan, TANG Wenyan. Related factors affecting delayed thyroid stimulating hormone elevation in preterm infants with gestational age <34 weeks [J]. Journal of Clinical Pediatrics, 2023, 41(10): 675-679.